Martin Shkreli

UBS Financial Services, Inc. is a registered investment advisor and wealth management firm headquartered in Weehawken, New Jersey. The firm is a wholly-owned subsidiary of UBS Americas Inc., ultimately held by UBS Group AG (SWX: UBSG; NYSE: UBS) in Switzerland. Founded in 1969, UBS Financial Services provides investment advisory services to individuals, banks, thrift institutions, mutual funds and other investment companies, pension and employee benefit plans, trusts, estates, charities, corporations and other business and government entities.

Intrepid Capital Management, Inc. (Intrepid Capital) is a registered investment advisor headquartered in Jacksonville Beach, Florida. The firm was founded by Forrest Travis and Mark Travis in 1994. They are a wholly-owned subsidiary of Intrepid Capital Corp. (NASDAQ: ICAP). Intrepid Capital provides advisory services and non-advisory services to corporate, institutional, and high net worth individuals. They also provide advisory services to mutual funds (registered investment companies) and pooled investment vehicles that are not registered as investment companies.

Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK.

Elea Capital Management LLC is a hedge fund manager located in New York City. They manage the Elea Partners LP

Founded in 2006, MSMB Capital Management LLC is a hedge fund manager located in New York City.

Retrophin, Inc. provides biotechnology services. It is a biotechnology company dedicated to developing drugs for rare and life-threatening diseases. The company was founded in 2011 and is headquartered in New York, NY.

Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland.